Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms-Reference-Cited by-同舟云学术

Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms

Published:2023-04-18 Issue:4 Volume:67 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Armengol Eva¹²,Kragh Kasper Nørskov¹^ORCID,Tolker-Nielsen Tim¹^ORCID,Sierra Josep M.²^ORCID,Higazy Doaa¹,Ciofu Oana¹,Viñas Miguel²,Høiby Niels¹³

Affiliation:

1. Costerton Biofilm Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

2. Laboratory of Molecular Microbiology & Antimicrobials, Department of Pathology & Experimental Therapeutics, Medical School and IDIBELL, University of Barcelona, Hospitalet de Llobregat, Spain

3. Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark

Abstract

The emergence of multidrug-resistant Pseudomonas aeruginosa infections has urged the need to find new strategies, such as the use of combinations of antibiotics. Among these, the combination of colistin with other antibiotics has been studied.

Funder

Fundació la Marató de TV3

UB | Campus Ciències de la Salut de Bellvitge, Universitat de Barcelona

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01641-22

Reference41 articles.

1. Multidrug Resistance in Bacteria

2. An overview of antimicrobial peptides and the latest advances in their development